Journal article
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
Abstract
Importance: The role of stereotactic ablative radiotherapy (SABR) for gynecologic malignant tumors has yet to be clearly defined despite recent clinical uptake.
Objective: To evaluate the outcomes of SABR in patients with oligometastatic and oligoprogressive gynecologic cancers.
Authors
Donovan EK; Lo SS; Beriwal S; Chen H; Cheung P; Keller A; Nwachukwu C; Mantz C; Pond GR; Schnarr K
Journal
JAMA Oncology, Vol. 10, No. 7, pp. 941–948
Publisher
American Medical Association (AMA)
Publication Date
July 1, 2024
DOI
10.1001/jamaoncol.2024.1796
ISSN
2374-2437